SCHEMBL20364191

SCHEMBL20364191

CCOP(C)(=O)C(C)C(=O)OC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA12 O43570 1/20 0.36
CA9 Q16790 1/20 0.36
TSHR P16473 4/20 0.36
GAA P10253 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
ACHE P22303 1/20 0.33
MGAM O43451 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10293871 0.83 PPARD (0.40) CA1CA2CA12CA9TSHR
SCHEMBL13790227 0.82 GAA (0.42) CA1CA2CA12CA9TSHR
SCHEMBL1691829 0.82 GAA (0.42) CA1CA2CA12CA9TSHR
SCHEMBL13724570 0.80 MMP1 (0.38) CA1CA2CA12CA9TSHR
SCHEMBL1879478 0.79 TSHR (0.39) CA1CA2CA12CA9TSHR
SCHEMBL12011596 0.79 SMN1; SMN2 (0.39) CA1CA2CA12CA9SMN1; SMN2
SCHEMBL18532983 0.78 GAA (0.41) CA1CA2CA12CA9TSHR
SCHEMBL2992495 0.73 CA2 (0.42) CA1CA2CA12CA9SMN1; SMN2
SCHEMBL10010011 0.73 ACHE (0.41) CA1CA2CA12CA9TSHR
SCHEMBL2990309 0.72 SMN1; SMN2 (0.38) CA1CA2CA12CA9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180194721-A1 DIFLUOROALKYLCYCLOPROPYL AMINO ACIDS AND ESTERS, AND SYNTHESES THEREOF ABBVIE INC. 2018-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180194721-A1 DIFLUOROALKYLCYCLOPROPYL AMINO ACIDS AND ESTERS, AND SYNTHESES THEREOF DNPEP, PEPD, ANPEP CA1 687/4885CA2 1757/4885CA12 1614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.